MedPath

Metabolome analysis of cachexia and its circadian rhythms in patients with advanced pancreatic cancer.

Not Applicable
Conditions
advanced pancreatic cancer
Registration Number
JPRN-UMIN000002384
Lead Sponsor
Medical Oncology, Kobe University Graduate School of Medicine
Brief Summary

evels of paraxanthine remained markedly lower in the cohort with cachexia at all measurement points. Besides, median IL-6 and TNF levels appeared higher and leptin concentration appeared lower in the cachexia group, albeit without statistical significance.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
21
Inclusion Criteria

Not provided

Exclusion Criteria

1. resectable pancreatic cancer 2. pancreatic neuroendcrine carcinoma 3. chemotherapy within 1 week 4. surgery within 1 month 5. deffinitive radiotherapy within 1 month 6. palliative radiotherapy within 2 weeks 7. uncontroled infection 8. uncontroled diabetic mellitus 9. condition that required corticosteroid

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The metabolites on cachexia by metabolom analysis
Secondary Outcome Measures
NameTimeMethod
The circadian rhythms of the metabolites on cachexia
© Copyright 2025. All Rights Reserved by MedPath